Helpline
Call 1.855.378.4373 to schedule a call time with a specialist or visit scheduler.drugfree.org
Helpline

Policymaker

We conduct research and advance policy to ensure those affected by addiction get the care and support they need.
Learn how we work with state agencies, policymakers, providers and clinical experts to improve patient care within the larger system.
The CDC recently released data indicating that the coronavirus pandemic has significantly exacerbated the addiction epidemic. Staggering overdose numbers should be a call-to-action for policymakers that we need to take a bold public health approach to addiction.
In collaboration with Legal Action Center we've explored key insurance barriers to affordable, timely and appropriate care for mental health and substance use. A four-report series offers recommendations to improve insurance regulation.
Medical necessity criteria should reflect generally accepted standards of care for the patient’s condition. Yet, for substance use disorders (SUDs), some health plans have used medical necessity criteria to restrict care and control costs.
Produced in collaboration with the Legal Action Center, this report analyzes requirements for public and private health plans to use specific criteria and assessment tools to determine medical necessity for substance use disorder benefits.
Traditional regulatory enforcement activities have proven inadequate to capture necessary compliance data or prevent the sale of sub-standard plans.
Produced in collaboration with the Legal Action Center, this report examines state parity compliance reporting requirements.
Partnership to End Addiction is part of a group of the nation’s leading experts in addiction research, treatment and policy, who released a comprehensive report outlining recommendations for addressing the opioid crisis.
This report was designed to support and empower state and local officials in making critical allocation decisions and consolidates the best research evidence available.
Contains recommendations and evidence-based strategies for investment of litigation settlement funds to end the opioid crisis and reduce future harm.
A 3D-animated series of advertisements features music by Grammy-nominated band The Lumineers. A podcast hosted by Emmy Award-winning journalist and bestselling author Elizabeth Vargas has also launched.
Join us August 31 to raise awareness that overdose death is preventable and to reduce the stigma associated with drug-related death.
Find our latest positions on today's most pressing addiction issues.
This report, produced in collaboration with Legal Action Center, discusses federal and state regulation and enforcement of the Parity Act with regard to network adequacy.
Health insurance providers must cover a full continuum of services and a robust network of providers to ensure access to mental health and substance use disorder treatment. This report examines network adequacy standards.
This book reveals how our addiction treatment industry is broken, highlights what is working, and shares insights about how it could be more effective.
A teen who reaches age 21 without smoking, using illegal drugs or alcohol is nearly certain never to do so. America needs to act on this information.
The groundbreaking method that helps loved ones conquer addiction and compulsion problems through positive reinforcement and kindness.
Addiction is a preventable, treatable disease, not a moral failing. As with other illnesses, the approaches most likely to work are based on science — not on faith, tradition, contrition, or wishful thinking.
This annual survey helps parents better understand the experiences, attitudes, perceptions, and behaviors of their children in relation to substance use.
There are numerous barriers to addiction treatment, but cost and lack of insurance coverage are the most common reasons people forgo the care they need.
Young children are being accidentally exposed at unacceptably high rates to toxic, addictive substances, but there are steps we can take.
The Parity Act has not put an end to restrictive coverage and limited reimbursement for substance use treatment in either private insurance or Medicaid.